Connor, Clark & Lunn Investment Management (CC&L)
SYRE icon

Connor, Clark & Lunn Investment Management (CC&L)’s Spyre Therapeutics SYRE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SYRE Stock Details SYRE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-646
Closed -$149K – 1115
2020
Q2 		$149K Buy
+646
New +$149K ﹤0.01% 926